The Missed Value of Underutilizing Pediatric Epilepsy Surgery: A Systematic Review

Christopher W Beatty1, Jason P Lockrow2, Satyanarayana Gedela3

  • 1The Ohio State University and Nationwide Children's Hospital, Division of Neurology, Department of Pediatrics, Columbus, OH.

Insights

Pediatric epilepsy surgery is underutilized, despite its long-term benefits. Addressing family, provider, and system-level barriers can improve access to this vital treatment for children with drug-resistant epilepsy (DRE).

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Health Services Research

Background:

  • Pediatric epilepsy surgery remains significantly underutilized, with only 1%-11% of children with drug-resistant epilepsy (DRE) receiving surgical treatment.
  • Less than half of pediatric epilepsy patients who could benefit from surgery actually undergo the procedure.

Purpose of the Study:

  • To systematically review factors contributing to the underutilization of pediatric epilepsy surgery.
  • To evaluate the impact of underutilization on individual patients and the healthcare system.

Main Methods:

  • A systematic review of articles was conducted using major scientific databases: PubMed, EMBASE, and Web of Science.
  • The review focused on identifying factors associated with surgery underutilization and its consequences.

Main Results:

  • Key factors contributing to underutilization include family misconceptions, insufficient provider knowledge, and systemic health disparities.
  • Despite significant upfront costs, pediatric epilepsy surgery offers long-term financial advantages and reduced healthcare resource utilization.
  • Timely surgical intervention improves seizure control and cognitive outcomes with a low complication rate.

Conclusions:

  • Interventions are necessary at family, provider, and healthcare system levels to enhance access to pediatric epilepsy surgery.
  • Increasing access to pediatric epilepsy surgery can lead to improved patient outcomes and healthcare efficiencies.

Related Concept Videos

Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
132
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
367
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
35
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34